These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34782381)
1. Policy in focus: Is psilocybin the next cannabis? Basky G CMAJ; 2021 Nov; 193(45):E1741-E1742. PubMed ID: 34782381 [No Abstract] [Full Text] [Related]
2. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]. Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346 [No Abstract] [Full Text] [Related]
3. Compassionate use of psychedelics. Greif A; Šurkala M Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195 [TBL] [Abstract][Full Text] [Related]
4. Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy. Mocanu V; Mackay L; Christie D; Argento E Subst Abuse Treat Prev Policy; 2022 May; 17(1):37. PubMed ID: 35568884 [TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Carhart-Harris RL; Goodwin GM Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617 [TBL] [Abstract][Full Text] [Related]
7. The emerging role of psilocybin and MDMA in the treatment of mental illness. Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; Ho R; McIntyre RS Expert Rev Neurother; 2020 Dec; 20(12):1263-1273. PubMed ID: 32954860 [TBL] [Abstract][Full Text] [Related]
8. Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Bogenschutz MP Curr Drug Abuse Rev; 2013 Mar; 6(1):17-29. PubMed ID: 23627783 [TBL] [Abstract][Full Text] [Related]
9. [Treatment with psilocybin: applications for patients with psychiatric disorders]. Breeksema JJ; Koolen MHB; Somers M; Schoevers RA Ned Tijdschr Geneeskd; 2021 Jan; 165():. PubMed ID: 33560605 [TBL] [Abstract][Full Text] [Related]
11. Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations. Ortiz CE; Dourron HM; Sweat NW; Garcia-Romeu A; MacCarthy S; Anderson BT; Hendricks PS Neuropharmacology; 2022 Aug; 214():109127. PubMed ID: 35577136 [TBL] [Abstract][Full Text] [Related]
12. Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Thomas K; Malcolm B; Lastra D J Psychoactive Drugs; 2017; 49(5):446-455. PubMed ID: 28481178 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects. Hosanagar A; Cusimano J; Radhakrishnan R J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988926 [No Abstract] [Full Text] [Related]
14. Reflections on the Concord Prison project and the follow-up study. Metzner R J Psychoactive Drugs; 1998; 30(4):427-8. PubMed ID: 9924846 [No Abstract] [Full Text] [Related]